Marrying precision med and AI, Groupon co-founder Eric Lefkofsky takes total haul for his analytics firm over the $1B line
The pandemic has taken Tempus — the company Groupon co-founder Eric Lefkofsky launched to bring artificial intelligence to physicians and researchers focused on precision medicine — in quite a few unexpected turns.
Not only did it launch efforts to help doctors in their core field of cancer adapt to new ways of working, it also made a decision to expand into infectious diseases (starting with Covid-19), while doubling down on depression and cardiology.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.